Innovation
13 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 278 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 3 |
Social engagement
Social engagement: 1.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record; lead investors include Invus, Sanofi Ventures, Venrock, J. Wood Capital Advisors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Private equity | 1 | 25% |
| Bank & private debt | 1 | 25% |
Recent activity
20 Jun 2026
Event
MELAS Masterclass at the United Mitochondrial Disease Foundation
15 Jun 2026
Event
United Mitochondrial Disease Foundation MitoMed Conference
4 Jun 2026
Event
EUROMIT 2026